Pre-emption language in US drug labelling rules re-examined
This article was originally published in Scrip
Executive Summary
US President Barack Obama's directive ordering a broad review of pre-emption language in federal regulations is likely to lead to changes in recent FDA rules on drug labelling and "changes being effected" (CBE) supplements.